Literature DB >> 24648670

Prevalence of cervical dysplasia in western Uttar Pradesh.

Kamna Gupta1, Nisha Puniya Malik1, Veena K Sharma1, Nidhi Verma1, Abhilasha Gupta2.   

Abstract

INTRODUCTION: Cervical intraepithelial neoplasia and cervical cancer remain important health problems. Cervical cytology by Papanicolaou (Pap) smears is an effective means of screening for cervical premalignant and malignant conditions. AIM: The aim of this study was to assess the prevalence of cervical dysplasia in pre- and postmenopausal women in western Uttar Pradesh and to find out risk factors as far as possible.
MATERIALS AND METHODS: A total of 4,703 cases were enrolled, cervical scrape smears were collected and stained using Papanicolaou's method and hematoxylin and eosin stain. The emphasis was put on epithelial abnormalities and smears were classified according to The Bethesda System 2001.
RESULTS: 81.06% (3812) smears were satisfactory according to The Bethesda System. Maximum numbers of cases (40.37%) were in age group 30-39 years. The epithelial abnormalities constituted 3.23% of all cases. Low-grade squamous intraepithelial lesion (LSIL) formed the largest number (1.36%), while high-grade squamous intraepithelial lesion (HSIL) formed 0.91%. Eleven cases of squamous cell carcinoma (SCC) were detected. The study has shown a relatively high prevalence of epithelial abnormalities in cervical smears with increasing age, parity, early age at first coitus (<20 year), and lower socioeconomic status in symptomatic women with clinical lesions on per speculum examination.
CONCLUSION: Epithelial abnormalities of cervix are not uncommon in our setup and are associated with early age at marriage and parity.

Entities:  

Keywords:  Carcinoma cervix; HSIL; LSIL; cervical intraepithelial neoplasia; papanicolaou smear

Year:  2013        PMID: 24648670      PMCID: PMC3945627          DOI: 10.4103/0970-9371.126659

Source DB:  PubMed          Journal:  J Cytol        ISSN: 0970-9371            Impact factor:   1.000


Introduction

Carcinoma cervix worldwide accounts for 15% of all cancers diagnosed in women.[1] Cervical cancer is one of the leading cancer in women with the estimated 5.0 lakhs new cases every year of which 80% occur in developing countries.[2] In India, it is estimated that the number of new cases are over 140,000.[3] Cancer cervix occupies the top rank or second among cancers in women in developing countries, whereas in the affluent countries cancer cervix does not find a place even in top five leading cancers in women. Seventy percent or more of these cancers are in the stage 3 or higher at the time of diagnosis. The role of Papanicolaou (Pap) smear as a cancer screening tool for the cervix has been substantiated by several studies in the last 50 years,[45] and the method has resulted in falling incidence and mortality of cervical cancer in the developed world.[678] Time trend analysis of a 10-year data in Bangalore, Bombay, and Madras and a 4-year data in Delhi did not reveal a statistically significant decrease or increase in the incidence of uterine cervical cancer for most of the age groups.[9] Therefore, the data on the prevalence of cervical epithelial abnormalities in various population in this country is not known. There is an urgent need for initiation of community screening and educational programs for the control and prevention of cervical cancer in India.[10] Therefore, objective of this study was to assess the prevalence of cervical dysplasia in pre and postmenopausal women in western Uttar Pradesh.

Materials and Methods

A total of 4,703 cases were enrolled. Detailed clinical history and pelvic examination (per speculum and per vaginal) were done. Cervical scrape smears were collected using Ayer's spatula or endocervical brush, the smears were fixed in absolute alcohol and stained using Papanicolaou's method and hematoxylin and eosin (H and E) stain. The epithelial abnormalities were classified according to The Bethesda System 2001.[11] All the cases above 18 years of age were studied and grouped as pre- and postmenopausal. Pregnant women, menstruating women, women with invasive carcinoma at the time of clinical evaluation, and women previously treated for cervical neoplasm were excluded from the study.

Results

In our study, we had examined 4,703 cases; out of which 3,812 (81.06%) smears were satisfactory according to The Bethesda System. The epithelial cell abnormalities constituted 3.2% of all cases and rest of 3,690 cases (96.8%) fell in the category of negative for intraepithelial lesion or malignancy (NILM). Maximum number of cases (40.37%) were in age group 30-39 years, followed by 35.96% in age group 20-29 years. The epithelial abnormalities including (atypical squamous and glandular cells of undetermined significance (ASCUS), atypical glandular cells of undetermined significance (AGUS), low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), and squamous cell carcinoma (SCC)) constituted 3.2% of all cases. LSIL [Figure 1] formed the largest number 1.36%, while HSIL [Figure 2] formed 0.91%. Eleven cases of SCC were detected [Table 1]. Different risk factors associated with dysplasia and cervical carcinoma detected in the present study were analyzed in detail. The findings are summarized below.
Figure 1

Photomicrograph from a case of low-grade squamous intraepithelial lesion showing koilocytes (Pap, × 400)

Figure 2

Photomicrograph showing high-grade squamous intraepithelial lesion (Pap, × 400)

Table 1

Distribution of cervical cytological findings in the subjects

Photomicrograph from a case of low-grade squamous intraepithelial lesion showing koilocytes (Pap, × 400) Photomicrograph showing high-grade squamous intraepithelial lesion (Pap, × 400) Distribution of cervical cytological findings in the subjects

Age

The frequency of dysplasia and cervical carcinoma in relation to age is shown in Table 2. A progressive rise was seen in the frequency of cytopathological abnormalities with increasing age, and maximum frequency of LSIL, HSIL, and cervical carcinoma was observed in age above 40 years.
Table 2

Age-wise distribution of smears and prevalence of dysplasia

Age-wise distribution of smears and prevalence of dysplasia

Age at first coitus

The frequency of dysplasia and cervical carcinoma in relation to age at first coitus is shown in Table 3. The frequency of LSIL was maximum in age group >30 years at first coitus, while HSIL and cervical carcinoma was maximum in patients who were <20 years at the time of first coitus.
Table 3

Association of dysplasia with age at first coitus

Association of dysplasia with age at first coitus

Parity

The frequency of dysplasia and cervical carcinoma in relation to parity is shown in Table 4. There was progressive rise of dysplasia with increasing parity, it was maximum in parity above 3.
Table 4

Association of dysplasia with parity

Association of dysplasia with parity

Gynecological symptoms

The frequency of dysplasia and cervical carcinoma in relation to gynecological symptoms is shown in Table 5. The frequency of dysplasia LSIL was higher in symptomatic women complaining of postcoital bleeding per vaginum, while frequency of HSIL and carcinoma cervix was highest with postmenopausal bleeding.
Table 5

Association of cervical dysplasia with presenting complaint

Association of cervical dysplasia with presenting complaint

Per speculum findings

The frequency of dysplasia and cervical carcinoma in relation to per speculum finding is shown in Table 6. The frequency of dysplasia and carcinoma cervix was very high in women with clinical lesions of cervix and the difference was statistically highly significant (P < 0.01), thus it was amply clear that clinical lesions of cervix harbor a large number of dysplasia and if such women are subjected to mandatory cytological evaluation, the burden of carcinoma cervix can be significantly reduced. Prevalance of epithelial abnormalities were ASCUS 0.52%, atypical squamous cells-cannot exclude HSIL (ASC-H) 0.05%, AGUS 0.05%, LSIL 1.36%, HSIL 0.91%, and for SCC 0.28%.
Table 6

Association of dysplasia with per speculum finding

Association of dysplasia with per speculum finding

Religion

Out of 3,812 cases; 2,744 smears (71.98%) were from Hindu patients while 1,060 smears (27.8%) belonged to Muslims and eight cases were from other religion. In Hindus, percentage positivity for LSIL and HSIL was 1.31 and 0.67%, respectively which was slightly higher in Muslims (LSIL 1.42%, HSIL 1.60%), but it was not statistically significant.

Socioeconomic status

All these 3,812 cases were classified according to Kuppuswamy classification into upper, middle, and lower class. Prevalence of LSIL, HSIL, and SCC in upper class was 1.31, 0.34, and 0; in middle class 1.02, 0.80, and 0.2%; in lower class it was 1.62, 0.94, and 0.4%, respectively. Though the percentage positivity of cervical dysplasia was higher in lower socioeconomic group but it was not statistically significant from the other two socioeconomic groups.

Smoking

The prevalence of dysplasia was more in smokers (17.24%) as compared to nonsmokers (2.61%), but the difference was not statistically significant. As the number of patients were very few who smoked, the association of smoking with dysplasia cannot be predicted.

Discussion

Uterine cervix is ideal for screening due to easy accessibility of cervix for inspection, palpation, exfoliative cytology, and screening. Cancer cervix is a preventable and curable disease due to effective screening methods available and a long preinvasive phase of the disease and various treatment modalities available. Cervical cancer screening represents one of the great success stories in cancer prevention. We studied Pap smears of 4,703 females. Out of which only 81.06% (3,812) were found to be satisfactory. Only 13.94% smears were unsatisfactory, the proportion of inadequate smears ranged from 0.2-5%[1213141516] in other studies. With reference to the epithelial abnormalities, which was the main reason for advocating routine cervical smear examination, the prevalence studies around the world has shown a wide range from as low as 0.98%[17] to as high as 15.6%.[18] No consistent pattern emerged in these studies both in developed and developing countries. Hence, within these countries such as US prevalence rates of cervical dysplasia range from 2.3-6.6%[19] in Middle East 1.65-7.9%,[202122] in Israel 0.98 to 4.41%,[232425] and in India 1.392-7.8%[26272829]; while in our study it was 3.23%. The reasons for these variation could be many including criteria employed for diagnosis, the quality checks used, intrinsic differences in the population studied including the prevalence of risk factors and the numbers studied which have ranged from as few as 419[18] to as high as 297,849.[17] A more detailed analysis showed the prevalence of LSIL (1.36%) was similar to many other studies from Zimbawe, Saudi Arabia, and USA. In our study, prevalence of LSIL was more common in premenopausal age group 40 years. It was noticed that in the majority of studies including ours, prevalence of HSIL formed less than 1% of the abnormal smears. Prevalence of HSIL was higher in postmenopausal women in our study. The percentage of dysplastic smears was found to be very high in women who were married at age <20 years, thus high parity coupled with early age at first coitus appeared to play a significant role in progression of cervical dysplasia. The studies of Castapeda-Ipiguez et al.,[30] have also pointed out the number of pregnancies as a great risk factor in the development of cervical dysplasia. As our study showed that frequency of cervical cancer was higher in women with postmenopausal bleeding, hence such women should always undergo mandatory cytological examination. A large number of workers[3132] found smoking as one of the major risk factor. In our study, dysplasia was found to be slightly more frequent in smokers as compared to nonsmokers, but statistically the difference was not significant. As regards association of smoking with dysplasia, it is very difficult to comment upon as the number of smoker females were too less in this study. The role of circumcision and carcinoma of cervix has been emphasized by a large number of workers in the past[333435] who reported carcinoma cervix to be more common in Hindus than in any other religion. The number of positive smears was more common in Muslims (3.20%) in comparison to Hindus (2.26%), but the difference was not statistically significant in this study. Terris et al.,[36] also found no significant difference in the circumcision status of marital partners of cases and control. It has been documented earlier that cancer is common in low socioeconomic class in whom the component of poverty, overcrowding, inadequate food, and poor personal hygiene are contributing factors. The increased risk with low socioeconomic status is attributed to a lack of screening, failure to treat precancerous conditions, and lack of knowledge about prevention of human papillomavirus (HPV) infection.[37] In our study, an inverse relation with socioeconomic status was observed as also in other studies. It has been established that low grade dysplasia is usually asymptomatic. The common complaints in high grade dysplasia are postmenopausal bleeding and intermenstrual and postcoital bleeding per vaginum.[38] In our study also, the most common complaint in both LSIL and HSIL was postcoital bleeding and postmenopausal bleeding per vaginum and on per speculum examination, most common finding was cervical polyp. In the past also, visual inspection of the cervix had been stressed by Sankaranarayanan et al.[39] Thus screening of both pre and postmenopausal women should be made mandatory as it helps in picking of cases of cervical intraepithelial neoplasia (CIN) which can be treated easily with different treatment modalities and progression of cervical precursors to invasive cancer can be reduced, thus reducing the incidence of cancer cervix.

Conclusion

The study has shown a relatively high prevalence of epithelial abnormalities in cervical smears and conventional Pap smear is a good tool to find cervical dysplasia in population. Periodical cytological screening would go a long way in the early detection of various cervical lesions and help in reducing the incidence of cervical cancer.
  37 in total

1.  Report on a Workshop of the UICC Project on Evaluation of Screening for Cancer.

Authors:  A B Miller; J Chamberlain; N E Day; M Hakama; P C Prorok
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

2.  Histological assessment of cytologically abnormal smears.

Authors:  A R Chitale; U R krishna
Journal:  Indian J Cancer       Date:  1976-12       Impact factor: 1.224

3.  Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes.

Authors:  E Lăără; N E Day; M Hakama
Journal:  Lancet       Date:  1987-05-30       Impact factor: 79.321

Review 4.  Effective screening programmes for cervical cancer in low- and middle-income developing countries.

Authors:  R Sankaranarayanan; A M Budukh; R Rajkumar
Journal:  Bull World Health Organ       Date:  2001-11-01       Impact factor: 9.408

5.  A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.

Authors:  Qinjing Pan; Jerome L Belinson; Ling Li; Robert G Pretorius; You Lin Qiao; Wen Hua Zhang; Xun Zhang; Ling Ying Wu; Sou De Rong; Yun Tian Sun
Journal:  Acta Cytol       Date:  2003 Jan-Feb       Impact factor: 2.319

6.  Cervical cancer screening in a rural population of Zimbabwe.

Authors:  P J Thistle; Z M Chirenje
Journal:  Cent Afr J Med       Date:  1997-09

7.  Premalignant lesions of the uterine cervix in a large cohort of Israeli Jewish women.

Authors:  O Sadan; E Schejter; S Ginath; R Bachar; M Boaz; J Menczer; M Glezerman
Journal:  Arch Gynecol Obstet       Date:  2003-10-24       Impact factor: 2.344

8.  Are Israeli women in a low risk group for developing squamous cell carcinoma of the uterine cervix?

Authors:  A Bar-Am; J Niv; H Yavetz; A J Jaffa; R M Peyser
Journal:  Acta Obstet Gynecol Scand       Date:  1995-07       Impact factor: 3.636

9.  Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85.

Authors:  G H Anderson; D A Boyes; J L Benedet; J C Le Riche; J P Matisic; K C Suen; A J Worth; A Millner; O M Bennett
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02

Review 10.  Cervical cancer screening in India: strategies revisited.

Authors:  A Juneja; A Sehgal; S Sharma; A Pandey
Journal:  Indian J Med Sci       Date:  2007-01
View more
  8 in total

1.  Cervical cancer awareness and presence of abnormal cytology among HIV-infected women on antiretroviral therapy in rural Andhra Pradesh, India.

Authors:  Sanghyuk S Shin; Catherine L Carpenter; Maria L Ekstrand; Qiao Wang; Surbhi Grover; Nicola M Zetola; Kartik Yadav; Sanjeev Sinha; Adeline M Nyamathi
Journal:  Int J STD AIDS       Date:  2019-02-27       Impact factor: 1.359

Review 2.  The Bethesda System for reporting cervical cytology.

Authors:  Meena A Pangarkar
Journal:  Cytojournal       Date:  2022-04-30       Impact factor: 2.345

3.  Screening Cervical Cancer by the Pap Test – Relevance of Age Ranges Recommended by the Brazilian Programme for Prevention and Control

Authors:  Diogo Do Nascimento Franco; Adriana Cunha Vargas Tomáz; Angela Andréia Franca Gravena; Sandra Marisa Pelloso; Márcia Edilaine Lopes Consolaro
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

4.  A study on cervical cancer screening in asymptomatic women using Papanicolaou smear in a tertiary care hospital in an urban area of Mumbai, India.

Authors:  Omna Shaki; Barun Kumar Chakrabarty; N Nagaraja
Journal:  J Family Med Prim Care       Date:  2018 Jul-Aug

5.  Safety and efficacy of the new CryoPop® cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controls.

Authors:  S Yogeshkumar; Jean Anderson; Enriquito Lu; Edward Kenyi; Margaret Mensa; Katrina Thaler; Ramalingappa Antartani; Kasturi Donimath; Basavaraj Patil; Santosh Chikaraddi; Shailaja Bidri; Aruna Biradar; Muttappa R Gudadinni; Laxmikant Lokare; Gayane Yenokyan; Mrutyunjaya B Bellad; Shivaprasad S Goudar; Richard Derman; Amit Revankar; Hema Patil; Ramadevi Wani; Ranjit Kangle; Ramesh Y Chavan; Mahantesh B Nagmoti; Yogendra M Kabadi; Purushotham Reddy; Sunita Vernekar; Surekha Hipparagi; Vijayalaxmi Patil; Anita Dalal
Journal:  Trials       Date:  2021-12-13       Impact factor: 2.279

6.  A community-based cervical cancer screening program in Alappuzha district of Kerala using camp approach.

Authors:  Lakshmi Mohan; M Karthika
Journal:  J Family Med Prim Care       Date:  2022-03-10

7.  A Study on Cervical Cancer Screening Using Pap Smear Test and Clinical Correlation.

Authors:  Pushp Lata Sachan; Meenakshi Singh; Munna Lal Patel; Rekha Sachan
Journal:  Asia Pac J Oncol Nurs       Date:  2018 Jul-Sep

8.  The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women.

Authors:  Heling Bao; Xiaorong Sun; Yi Zhang; Baochuan Pang; Hua Li; Liang Zhou; Fengpin Wu; Dehua Cao; Jian Wang; Bojana Turic; Linhong Wang
Journal:  Cancer Med       Date:  2020-07-22       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.